Home/Filings/4/0000879169-25-000009
4//SEC Filing

Issa Mohamed Khairie 4

Accession 0000879169-25-000009

CIK 0000879169other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:11 PM ET

Size

5.2 KB

Accession

0000879169-25-000009

Insider Transaction Report

Form 4
Period: 2025-01-06
Issa Mohamed Khairie
EVP, Head of US Oncology
Transactions
  • Award

    Common Stock

    2025-01-06+48,67148,671 total
Footnotes (2)
  • [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
  • [F2]Includes the January 6, 2025 aggregate grant of 48,671 shares of common stock.

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0002050035

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:11 PM ET
Size
5.2 KB